BioAge Labs, Inc. (BIOA)
5.87
-0.07
(-1.18%)
USD |
NASDAQ |
Oct 30, 16:00
5.90
+0.03
(+0.51%)
After-Hours: 20:00
BioAge Labs Cash and Short Term Investments (Annual) : 281.10M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 281.10M |
| December 31, 2024 | 354.35M |
| Date | Value |
|---|---|
| December 31, 2023 | 24.96M |
| December 31, 2022 | 27.64M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Neumora Therapeutics, Inc. | 182.53M |
| Alumis, Inc. | 308.58M |
| ANI Pharmaceuticals, Inc. | 294.75M |
| Corcept Therapeutics, Inc. | 372.15M |
| Veru, Inc. | 18.32M |